We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VITL icon
626
Vital Farms
VITL
$580M
$287K ﹤0.01%
6,146
-6,993
-53% -$241K
PHM icon
627
Pultegroup
PHM
$24.6B
– –
0
– –
CNQ icon
628
Canadian Natural Resources
CNQ
$93.6B
$281K ﹤0.01%
7,886
– –
GPC icon
629
Genuine Parts
GPC
$17.7B
$280K ﹤0.01%
2,023
+116
+6% +$17.3K
IP icon
630
International Paper
IP
$22.6B
$277K ﹤0.01%
6,421
-713
-10% -$29K
CTMX icon
631
CytomX Therapeutics
CTMX
$721M
$256K ﹤0.01%
+210,027
New +$418K
KB icon
632
KB Financial Group
KB
$41.3B
$242K ﹤0.01%
4,279
-11,721
-73% -$637K
HQY icon
633
HealthEquity
HQY
$8.34B
$240K ﹤0.01%
+2,784
New +$225K
AEO icon
634
American Eagle Outfitters
AEO
$2.94B
$240K ﹤0.01%
+12,000
New +$274K
BCE icon
635
BCE
BCE
$19.9B
$234K ﹤0.01%
7,236
– –
ASX icon
636
ASE Group
ASX
$78.5B
$230K ﹤0.01%
+20,120
New +$218K
KGC icon
637
Kinross Gold
KGC
$28.3B
$228K ﹤0.01%
27,386
-11,179
-29% -$80.9K
TPL icon
638
Texas Pacific Land
TPL
$27.7B
$220K ﹤0.01%
900
-900
-50% -$189K
RSG icon
639
Republic Services
RSG
$67B
$201K ﹤0.01%
+1,032
New +$195K
GFI icon
640
Gold Fields
GFI
$29.2B
$189K ﹤0.01%
+12,675
New +$206K
UMC icon
641
United Microelectronic
UMC
$47B
$180K ﹤0.01%
+20,525
New +$169K
GRAL
642
GRAIL Inc
GRAL
$2.89B
$160K ﹤0.01%
+10,431
New +$169K
BBD icon
643
Banco Bradesco
BBD
$38.4B
$115K ﹤0.01%
+51,535
New +$133K
NKTR icon
644
Nektar Therapeutics
NKTR
$2.37B
$98.7K ﹤0.01%
+5,306
New +$112K
CIG icon
645
CEMIG Preferred Shares
CIG
$6.15B
$58.6K ﹤0.01%
+33,294
New +$63.7K
ACAD icon
646
Acadia Pharmaceuticals
ACAD
$4.4B
– –
-405,751
Closed -$7.5M
AKRO
647
DELISTED
Akero Therapeutics
AKRO
– –
-240,000
Closed -$6.06M
ARDX icon
648
Ardelyx
ARDX
$1.27B
– –
-230,000
Closed -$1.68M
AVY icon
649
Avery Dennison
AVY
$12.5B
– –
-1,522
Closed -$340K
AXSM icon
650
Axsome Therapeutics
AXSM
$12.3B
– –
-75,084
Closed -$5.99M
24 25
26
27 28

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.